
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
07/11/2025 | Q2 | -- | $416.9M | -$0.05 | -- | -- |
04/30/2025 | Q1 | -- | $380.5M | -$0.03 | -- | -- |
02/12/2025 | Q4 | -- | $389.2M | -$0.00 | -- | -- |
10/24/2024 | Q3 | -- | $719.2M | $0.01 | -- | -- |
07/12/2024 | Q2 | -- | $765.1M | $0.13 | -- | -- |
04/18/2024 | Q1 | -- | $434.1M | -$0.07 | -- | -- |
02/08/2024 | Q4 | -- | $448.5M | -$0.07 | -- | -- |
10/25/2023 | Q3 | -- | $737.7M | -$0.07 | -- | -- |
07/14/2023 | Q2 | -- | $832.9M | $0.01 | -- | -- |
03/31/2023 | Q1 | -- | $941.5M | $0.15 | -- | -- |
12/31/2022 | Q4 | -- | $997.6M | $0.14 | -- | -- |
09/30/2022 | Q3 | -- | $1.1B | $0.48 | -- | -- |
06/30/2022 | Q2 | -- | $1.3B | $0.49 | -- | -- |
03/31/2022 | Q1 | -- | $1.3B | $0.47 | -- | -- |
12/31/2021 | Q4 | -- | $1.2B | $0.36 | -- | -- |
09/30/2021 | Q3 | -- | $983.5M | $0.24 | -- | -- |
06/30/2021 | Q2 | -- | $854.2M | $0.12 | -- | -- |
03/31/2021 | Q1 | -- | $823.1M | $0.14 | -- | -- |
12/31/2020 | Q4 | -- | $767.5M | $0.02 | -- | -- |
09/30/2020 | Q3 | -- | $626.2M | -$0.02 | -- | -- |
06/30/2020 | Q2 | -- | $567.5M | -$0.00 | -- | -- |
03/31/2020 | Q1 | -- | $596.3M | $0.05 | -- | -- |
12/31/2019 | Q4 | -- | $593.1M | $0.00 | -- | -- |
09/30/2019 | Q3 | -- | $618.9M | $0.04 | -- | -- |
06/30/2019 | Q2 | -- | $652.4M | $0.03 | -- | -- |
03/31/2019 | Q1 | -- | $665.3M | $0.10 | -- | -- |
12/31/2018 | Q4 | -- | $709.5M | $0.08 | -- | -- |
09/30/2018 | Q3 | -- | $701.5M | $0.19 | -- | -- |
06/30/2018 | Q2 | -- | $880.4M | $0.28 | -- | -- |
03/31/2018 | Q1 | -- | $816M | $0.16 | -- | -- |
12/31/2017 | Q4 | -- | $765.1M | $0.14 | -- | -- |
09/30/2017 | Q3 | -- | $660.4M | $0.08 | -- | -- |
06/30/2017 | Q2 | -- | $598.8M | $0.05 | -- | -- |
03/31/2017 | Q1 | -- | $537.7M | -$0.02 | -- | -- |
Elkem ASA reported $416.9M worth of top line sales in its most recent quarter.
Elkem ASA announced earnings per share of -$0.05 which represents a miss of analyst forecast a -- per share.
Elkem ASA reported $217.6M that represents $0.34 per share over the last quarter.
Elkem ASA's earnings are forecast to grow from $0.07 per share to -- per share next year representing an increase of --.
Elkem ASA's next earnings date is October 23, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.